Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
 <li>
<a href="https://smartkarma.com/entities/bewith-inc">Bewith</a> is navigating a strategic pivot, with operating profit growth (9.1% YoY in FY05/26) and a strong FY05/27 forecast (+37.1% YoY) despite a recent minor revenue decline (-0.3% YoY).</li>
 <li>The company is shifting its focus from contracting public-sector projects to higher-growth commercial sectors like finance, telecommunications, and retail, leveraging its proprietary 'Omnia LINK' technology platform.</li>
 <li>Key risks center on execution of this strategic shift and offsetting the revenue impact from the shrinking public-sector business, while a high dividend yield (4.84%) provides valuation support.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Bewith is navigating a strategic pivot, with operating profit growth (9.1% YoY in FY05/26) and a strong FY05/27 forecast (+37.1% YoY) despite a recent minor revenue decline (-0.3% YoY).
  The company is shifting its focus from contracting public-sector projects to higher-growth commercial sectors like finance, telecommunications, and retail, leveraging its proprietary 'Omnia LINK' technology platform.
  Key risks center on execution of this strategic shift and offsetting the revenue impact from the shrinking public-sector business, while a high dividend yield (4.84%) provides valuation support.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

<ul><li>In FY05/26, revenue declined 0.3% YoY, while operating profit increased 9.1% YoY, exceeding forecasts.</li><li>For FY05/27, Bewith forecasts revenue of JPY38.3bn (+5.4% YoY) and operating profit of JPY1.6bn (+37.1% YoY).</li><li>By FY05/31, Bewith targets revenue of JPY46.0bn (CAGR of 4.8%) and operating profit of JPY3.0bn (CAGR of 20.8%).</li></ul>

In FY05/26, revenue declined 0.3% YoY, while operating profit increased 9.1% YoY, exceeding forecasts.For FY05/27, Bewith forecasts revenue of JPY38.3bn (+5.4% YoY) and operating profit of JPY1.6bn (+37.1% YoY).By FY05/31, Bewith targets revenue of JPY46.0bn (CAGR of 4.8%) and operating profit of JPY3.0bn (CAGR of 20.8%).

Bewith (9216 JP): Full-year FY05/26 flash update

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Today, <a href="https://www.smartkarma.com/entities/dai-ichi-life-insurance" target="_blank" data-smartkarma-citation="entities:1109:1" rel="noopener">Dai Ichi Life Insurance (8750 JP)</a>  announced a proposed counter/over-bid for <a href="https://www.smartkarma.com/entities/benefit-one-inc" target="_blank" data-smartkarma-citation="entities:14502:1" rel="noopener">Benefit One Inc (2412 JP)</a>. ¥1800/share for minorities and a better (undefined) outcome for <a href="https://www.smartkarma.com/entities/pasona-group-inc" target="_blank" data-smartkarma-citation="entities:15778:1" rel="noopener">Pasona Group (2168 JP)</a>. </li>
<li>This throws the cat amongst the pigeons as it is unsolicited, for 100% not just to get Pasona's stake, and it will require Benefit One recommend or not.</li>
<li>For Pasona, this deal structure would likely increase the net result from the stake sale, possibly substantially so. It's in the details. </li>
</ul>


Today, Dai Ichi Life Insurance (8750 JP)  announced a proposed counter/over-bid for Benefit One Inc (2412 JP). ¥1800/share for minorities and a better (undefined) outcome for Pasona Group (2168 JP). 
This throws the cat amongst the pigeons as it is unsolicited, for 100% not just to get Pasona's stake, and it will require Benefit One recommend or not.
For Pasona, this deal structure would likely increase the net result from the stake sale, possibly substantially so. It's in the details. 


New Deal for Benefit One (2168) Could Mean Lots More Money for Pasona (2168)

<ul>
<li>As discussed <a href="https://www.smartkarma.com/insights/big-m3-2413-partial-tob-as-pasona-sells-control-of-benefit-one-2412-really-interesting-dynamics" target="_blank" rel="noopener">here</a> in a piece about the Partial Tender Offer<a href="https://www.smartkarma.com/insights/big-m3-2413-partial-tob-as-pasona-sells-control-of-benefit-one-2412-really-interesting-dynamics" target="_blank" data-smartkarma-citation="insights:117493" rel="noopener"></a>, Pasona Group (2168) has agreed to sell its controlling stake in Benefit One (2412) to M3 (2413).</li>
<li>That will leave Pasona Group with a fair chunk of cash and possibly a residual stake in Benefit One, depending on the results.</li>
<li>Though we don't know what the future holds, Pasona now is the wrong price for its future. </li>
</ul>


As discussed here in a piece about the Partial Tender Offer, Pasona Group (2168) has agreed to sell its controlling stake in Benefit One (2412) to M3 (2413).
That will leave Pasona Group with a fair chunk of cash and possibly a residual stake in Benefit One, depending on the results.
Though we don't know what the future holds, Pasona now is the wrong price for its future. 


Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in margin trading positions of JPX stocks as of Mar 27th. The aggregated net margin trading position is USD17,856m.</li>
<li>We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.</li>
<li>We highlight net margin buy/sell changes in Fujikura, SoftBank, Sanrio, West Japan Railway Company, Advantest, Kioxia, Honda Motor, Kyushu Railway Company, Sumitomo Metal Mining, SBI.</li>
</ul>


We analyzed the changes in margin trading positions of JPX stocks as of Mar 27th. The aggregated net margin trading position is USD17,856m.
We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
We highlight net margin buy/sell changes in Fujikura, SoftBank, Sanrio, West Japan Railway Company, Advantest, Kioxia, Honda Motor, Kyushu Railway Company, Sumitomo Metal Mining, SBI.


JPX Margin Trading Weekly (Mar 27th): Fujikura, SoftBank, Sanrio, West Japan Railway Company

Japan

Bewith,Inc. provides contact center and and business process outsourcing (BPO) services. The Company also offers various artificial intelligence, digital transformation solutions, application and platform, and related consulting services. Bewith conducts businesses in Japan.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bewith (9216 JP)

Primer: Bewith (9216 JP) - Aug 2026

Bewith is navigating a strategic pivot, with operating profit growth (9.1% YoY in FY05/26) and a strong FY05/27 forecast (+37.1% YoY) despite a...

αSK Primers

Bewith (9216 JP): Full-year FY05/26 flash update

In FY05/26, revenue declined 0.3% YoY, while operating profit increased 9.1% YoY, exceeding forecasts. For FY05/27, Bewith forecasts revenue of...

Shared Research

New Deal for Benefit One (2168) Could Mean Lots More Money for Pasona (2168)

Dai-Ichi Life proposed a full takeout of Benefit One which would lead to a different structured sale by Pasona. The structure of that sale would...

Travis Lundy

Pasona: The Wrong Price

Pasona is now trading ~65% of post-tender net after-tax cash+securities. Maybe cheaper. Pasona ex-Benefit One/ex-Bewith is guided to lose money...

Travis Lundy

JPX Margin Trading Weekly (Mar 27th): Fujikura, SoftBank, Sanrio, West Japan Railway Company

We analyzed JPX margin trading positions report for the past week and highlighted Fujikura (5803 JP), SoftBank (9984 JP), Sanrio (8136 JP), West...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)